← All updates
Observational study

Dermatology ·

Norepinephrine damages melanocytes in cultured human hair follicles

An organ-culture study tested norepinephrine exposure in human scalp hair follicles and assessed oxidative stress, DNA damage and melanocyte changes over seven days. The findings suggest β2-adrenergic receptor involvement, but experiments did not establish whether this pathway causes vitiligo-associated poliosis.

Researchers compared β2-adrenergic receptor immunoreactivity in hair follicles from vitiligo-associated poliosis and normally pigmented follicles, then examined cultured human scalp hair follicles exposed to 5 μmol/L norepinephrine for 1–7 days, with or without the selective β2-adrenergic receptor antagonist ICI-118551. The source does not report sample sizes for these comparisons or cultures.

After one day, norepinephrine increased malondialdehyde and 8-hydroxy-2′-deoxyguanosine, reduced superoxide dismutase activity and B-cell lymphoma 2 immunoreactivity, and depolarized mitochondrial membranes. At five to seven days, DNA-damage and cell-death signals increased, with progressive melanocyte ultrastructural injury. Norepinephrine also reduced pigmentation-related markers and shortened melanocyte dendrites; melanin staining rose initially and then declined. ICI-118551 attenuated the reported effects.

The findings support a possible β2-adrenergic receptor-linked oxidative-stress pathway affecting pigmentation in healthy human scalp follicles in culture. They do not show that this mechanism drives poliosis in vitiligo: functional experiments were not performed in vitiligo follicles, and organ-culture findings do not establish clinical effects or a treatment strategy.

AI summary · Not yet editor-reviewed

Is this summary clinically accurate?

Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.

Sign in to rate this summary →